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The purpose of the study was to evaluate the antibacterial effect of protoporphyrin IX (PpIX) 
generated by the exogenous administration of 5-aminolevulinic acid or δ-ALA and activated with an 
argon laser over a planktonic and biofilm of Enterococcus faecalis (E. faecalis) as a pharmacological 
therapy alternative. A planktonic strain of E. faecalis was cultured with a solution of ∂-ALA (40 
µg/mL)-thioglycolate solution for 13 min, and a biofilm of E. faecalis was cultured in a δ-ALA (80 
µg/mL)-thioglycolate solution for 13 min. Then, both were irradiated with an argon laser. Finally, 
the antibacterial effect was evaluated by counting the CFU in planktonic form, and a LIVE/DEAD 
viability cell test. The production and accumulation of PpIX from exogenously administered δ-ALA 
on E. faecalis in planktonic and biofilm forms was confirmed by spectrofluorometry. The irradiation 
of PpIX with an argon laser produced an antibacterial effect on E. faecalis in planktonic and biofilm 
form, even without biofilm disruption, at a concentration of 40 µg/mL and 80 µg/mL of δ-ALA, 
respectively. The exogenous administration of δ-ALA in combination with laser irradiation on 
planktonic and biofilm forms of E. faecalis produces an effective antibacterial effect as complement 
or alternative to pharmacological therapies.
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INTRODUCTION
Microbial infection remains among the leading 
causes of death worldwide (Barra et al., 2015). 
Enterococci, important healthcare-associated pathogens, 
cause serious and often life-threatening diseases. The 
variety of infections produced by Enterococci include 
urinary tract infections, intra-abdominal infections, 
pelvic infections (Gilmore et al., 2014), device-
associated infections (Darouiche, 2001), soft tissue 
infections, bacteremia and endocarditis (Gilmore 
et al., 2014).
Pathogenic bacteria, such as Enterococci, can 
attach to biotic or abiotic surfaces (Balcázar, Subirats, 
Borrego, 2015), forming a microbial community 
(Donlan, 2011; Li et al., 2013) in a three-dimensional 
extracellular polysaccharide matrix (EPM) (Balcázar, 
Subirats, Borrego, 2015; Barra et al., 2015; Li et al., 
2013; López-Jiménez et al., 2015) known as a biofilm 
(Balcázar, Subirats, Borrego, 2015). Additionally, some 
pathogenic bacteria can develop multidrug resistance 
due the abuse and incorrect use of pharmacological 
therapies (Barra et al., 2015).
Microorganisms in a biofilm are exposed to 
very different environmental conditions from those 
in planktonic form (López-Jiménez et al., 2015) and 
many species can change their metabolism depending 
on the surrounding physiological and physicochemical 
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conditions (Balcázar, Subirats, Borrego, 2015). One 
of the most important characteristics of biofilms is 
that the microorganisms in it are more resistant to 
pharmacological therapies as antimicrobials (Balcázar, 
Subirats, Borrego, 2015; Donlan, 2011; López-Jiménez et 
al., 2015) (up to 1000 time less susceptibility to specific 
antimicrobials) (Balcázar, Subirats, Borrego, 2015; 
Donelli, 2014; Li et al., 2013) and to the host immune 
defenses compared to their planktonic counterparts (Li 
et al., 2013), mainly because of the protection conferred 
by the EPM (Balcázar, Subirats, Borrego, 2015).
Mechanical disruption and pharmacological 
therapies are the most used methods to treat 
biofilms. However, the efficacy of these strategies 
is limited because of the persistence of biofilm 
and microorganisms after mechanical disruption 
and the appearance of antibiotic resistant strains 
(López-Jiménez et al., 2015; Rajesh et al., 
2011). Moreover, it was reported that the drug levels 
necessary to kill dispersed bacteria may be ineffective 
against biofilm associated bacteria (Donlan, 2011).
Photodynamic therapy (PDT) or photodynamic 
inactivation (PDI) is a clinical procedure that has been 
emerged as a non-invasive therapeutic modality for 
the treatment of infections (Dai et al., 2012; Rajesh 
et al., 2011; Sperandio, Huang, Hamblin, 2013). PDT 
was first reported by Dobson and Wilson (1992), 
and they suggest that photosensitization may be 
effective for eliminating periodontal pathogenic 
bacteria from dental plaque (Dobson, Wilson, 1992). 
This technique involves three components: a source 
of light, a photosensitizer agent (PS) and oxygen 
(Rajesh et al., 2011). One of the main advantages of 
PDT is the high target specificity because the PS is 
localized into the microorganisms without the major 
involvement of surrounding tissues or cells (Donelli, 
2014). Additionally, with PDT, it is possible to avoid 
the appearance of undesired drug resistant strains 
(Sperandio, Huang, Hamblin, 2013).
The action of PDT is related to the activation of 
PS by light of a specific wavelength (Breskey et al., 
2013; Pagonis et al., 2010; Rajesh et al., 2011; Soukos 
et al., 2006) in a non-thermal oxygen-dependent 
photochemical reaction (Rajesh et al., 2011; Sperandio, 
Huang, Hamblin, 2013), in which the PS undergo a 
transition from a low energy state to an excited state 
(triple state) (Homayoni et al., 2015; Sperandio, Huang, 
Hamblin, 2013). The triplet state photosensitizer can 
react with biomolecules by two main photochemical 
mechanisms called type I and type II (Rajesh et al., 
2011; Sperandio, Huang, Hamblin, 2013), by electron 
transfer or by energy transfer processes, respectively 
(Sperandio, Huang, Hamblin, 2013). The type I pathway 
forms superoxide anions that lead to the formation 
of reactive oxygen species (ROS), such as hydroxyl 
radicals, whereas the type II pathway leads to singlet 
oxygen production (Homayoni et al., 2015; Sperandio, 
Huang, Hamblin, 2013). Both processes produce a 
cytotoxic effect on bacteria (López-Jiménez et al., 2015; 
Pagonis et al., 2010).
The PS plays a key role in the efficacy of PDT 
because it should have specific characteristics for 
clinical use (Homayoni et al., 2015), such as the 
presence of absorption bands in the optical window 
in the red portion of the electromagnetic spectrum 
(600–900 nm) when deep light penetration is required 
(Sperandio, Huang, Hamblin, 2013; Wachowska 
et al., 2011). The PS should also have a high yield of 
the excited electronic triplet state and singlet oxygen 
(Sperandio, Huang, Hamblin, 2013). It should be 
selectively accumulated in host cells (Barra et al., 
2015), and should generate reactive oxygen species in 
the presence of light and oxygen (Sperandio, Huang, 
Hamblin, 2013). Furthermore, the PS should have low 
toxicity without light exposure and possess a relatively 
rapid clearance from normal tissues to minimize side 
effects (Breskey et al., 2013; Wachowska et al., 2011). 
Most PS agents cannot meet all these criteria; therefore, 
the final selection of the PS depends upon maintaining 
a balance between optimal photoreactivity and 
biological properties, which when combined with light 
irradiation, offers the most effective outcome with the 
lowest level of side effects (Breskey et al., 2013).
Porphyrin based photosensitizer agents have 
been approved clinically in the United States for PDT 
(Homayoni et al., 2015), and one of the most studied 
is protoporphyrin IX (PpIX) due to its properties. 
Unfortunately, it has some issues for clinical applications, 
such as hydrophobicity and low solubility in aqueous 
solutions (Homayoni et al., 2015), making it useless 
for deep tissues. By contrast, 5-aminolevulinic acid (5-
ALA) or delta-aminolevulinic acid (δ-ALA), a natural 
amino acid (Hino et al., 2013) and an early intermediate 
in the heme biosynthesis pathway (Wachowska et al., 
2011), although not a PS per se (Barra et al., 2015), is the 
precursor of the photosensitizer PpIX (Hino et al., 2013; 
Li et al., 2013). δ-ALA was used for photodynamic 
therapy for the first time in 1987 for the selective 
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elimination of erythroleukaemic cells (Malik, Lugaci, 
1987), which opened the possibility of a new approach 
for cell and bacteria therapy due to its properties of low 
lipid solubility and reduced bioavailability (Wachowska 
et al., 2011) but good solubility in water (Li et al., 2013). 
Moreover, when δ-ALA is taken up by target cells 
(bacteria), δ-ALA is metabolically transformed to PpIX 
(Barra et al., 2015). Furthermore, the accumulation of 
porphyrins is more pronounced in cells with high rates 
of metabolic activity, such as cancer cells, inflammatory 
cells and bacteria, resulting in high selectivity (Fotinos 
et al., 2008).
The aim of the present study was to determinate the 
antibacterial effect of the exogenous administration of 
δ-ALA to produce intracellular PpIX irradiated with an 
argon laser (500 mW, 510 nm, 200 J/cm2) on planktonic 
and biofilm forms of E. faecalis.
MATERIAL AND METHODS 
∂-ALA solution
Previous to the experimental work, the minimal 
inhibitory test was performed to determinate the 
effective dose of the ∂-ALA solution in combination 
with laser irradiation. For planktonic bacteria, 40 µg/mL 
was the required dose to obtain an antibacterial effect 
and a dose of 80 µg/mL was necessary for an effective 
antibacterial effect on biofilm.
The ∂-ALA (40 µg/mL)-thioglycolate and ∂-ALA 
(80 µg/mL)-thioglycolate solution (synthesized in the 
Environmental Cytopathology Laboratory, IPN, Mexico) 
were prepared, both enriched with vitamin K. Because 
it was reported that ∂-ALA production is significantly 
enhanced when the pH is maintained at neutral range 
(Sasaki et al., 1993), the pH of the thioglycolate solution 
was adjusted to 6.8-7.0 using NaOH 10 N.
Isolation of the strain and bacterial cell culture
An Enterococcus faecalis strain was isolated from 
teeth with endodontic treatment failure and a periapical 
lesion, according to the protocol described by Manzur 
(2007). To confirm isolation of the strain, the API 
System (BIOMÉRIEUX, USA) was used. The bacteria 
were cultured in 5 mL Falcon tubes with continuous 
shaking at 37 °C overnight. To determinate the bacterial 
amount, the optical density (OD) was adjusted to 1.0, 
which corresponds to approximately to 5X107 cells/mL. 
∂-ALA metabolism to PpIX into bacteria
To determine the production of PpIX after ∂-ALA 
administration, an aliquot of E. faecalis was incubated 
(Incubator Precision Thermo Electron Corporation, 
USA) with 2 mL of ∂-ALA (40 µg/mL)-thioglycolate 
solution with continuous shaking for 13 min at 37 °C. 
After the incubation, the sample was centrifuged 
(Centra CL2 Centrifuge, Thermo Electron Corporation, 
USA) at 5,000 RPM for 10 min. The supernatant was 
removed, the cell pellets were washed with 1 mL of PBS, 
and the samples were centrifuged again at 5,000 RPM 
for 5 min. Then, the supernatant was removed, and 1 
mL of a lysis solution (ethanol + dimethyl sulfoxide + 
acetic acid 80:20:1 V/V/V) was added to the samples 
that were then sonicated for 5 cycles for 5 sec. Next, 
the samples were centrifuged at 5,000 RPM for 3 min. 
Finally, the supernatant was transferred to a quartz 
cuvette and read with a spectrofluorometer (PTI Photon 
International Mod. 5020, USA). The measurements 
were recorded at 375 nm excitation with a wavelength 
range from 300 to 700 nm. All experiments were 
performed for triplicate.
Photosensibilitation PpIX determination
After the fluorescence of PpIX was identified 
by spectrofluorometry at 480 nm, the samples were 
irradiated with an argon laser type B, 500 mW (Leica 
Microsystems GmbH, Mannheim, Germany) at 510 
nm (LEICA Acousto Optical Tunable Filter enable 
to tune the WL) for 8 min, 33 sec to reach 200 J/cm2 
(Dosage calculation, power/beam area x time = J/cm²). 
Then, the samples were read by spectrofluorometry. 
The intensity of the fluorescence signal before and 
after laser irradiation was compared to determinate the 
photoactivation of PpIX.
Antibacterial effect of PpIX on planktonic E. faecalis
To evaluate the antibacterial effect on bacterial 
cells, 2 mL of culture medium (5x107 cells/mL) were 
treated as follows: group 1 (G1), a positive control group 
treated with 800 µL of thioglycolate + 200 µL of sodium 
hypochlorite (NaOCl) at 5.25%; group 2 (G2), 1 mL of 
thioglycolate + laser irradiation (8 min, 33 sec); group 
3 (G3), 1 mL δ-ALA (40 µg/mL)-thioglycolate solution 
(control groups); and group 4 (G4), 1 mL of δ-ALA (40 
µg/mL)-thioglycolate solution + laser irradiation for 8 
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min, 33 sec as the experimental group. Because there 
is previous evidence that there is not a significance 
difference between cultures treated only with laser 
irradiation or only δ-ALA, these groups were treated 
as negative control groups. A bacterial cell culture 
(extension technique) of each group was performed with 
a dilution of 1:10,000. Then, a CFU count of each group 
was performed at 0, 24 and 72 h.
Determination of the antibacterial 
effect of PpIX on E. faecalis biofilm
The formation of biofilm was performed following 
the protocols previously described by Kaplan et al. 
(2004), Djordjevic, Wiedmann and McLandsborough 
(2002) and Zaw Yuthika, Lakshman (2007). On a 24 well 
microplate with coverslips, 71 µL of the inoculum of E. 
faecalis (5x107 cell/mL) and 929 µL of 3% thioglycolate 
enriched with vitamin K were added. The samples were 
incubated for 10 days at 37 °C with continuous shaking. 
The medium was replaced every 24 hrs.
After, the biofilm samples were divided in 4 groups: 
group “a” (GA), a positive control group treated with 800 
µL of thioglycolate + 200 µL of NaOCl 5.25%; group 
“b” (GB), 1 mL of thioglycolate + laser irradiation (8 
min, 33 sec); group “c” (GC), 1 mL δ-ALA (80 µg/mL)-
thioglycolate solution; and group “d” (GD), 1 mL of 
δ-ALA (80 µg/mL)-thioglycolate solution (5X107cells/
mL) + laser irradiation to reach 200 J/cm2.
To determinate the bacteria viability, a LIVE/
DEAD Bacterial Viability Kit was used (Thermo 
Fisher Scientific, USA). Briefly, the culture medium 
from each well was removed with a Pasteur pipette 
to eliminate the non-adherent cells. Then, coverslips 
were placed in a new multiwall polystyrene plate under 
sterile conditions, and the biofilm was treated with 200 
µL of CTC (5-cyano-2,3 ditolyl tetrazolium chloride) 
to indicate the cellular respiratory activity. All samples 
were incubated for 12 h at 37 °C, with continuous 
shaking. Then, 200 µL of CTC was removed and 
washed with 1 mL of 1X PBS. The biofilm was covered 
with 200 µL of propidium iodide (PI), a fluorescent 
molecule impermeable to the cellular membrane and 
generally excluded from viable cells. Finally, the 
sample was placed on a glass slide and examined on an 
inverted TCS-SPE confocal microscope (DMI4000B, 
Leica Microsystems GmbH, Mannheim, Germany). 
The window of emission ranged from 500 to 520 nm 
for the PI and an excitation of 488 nm for the flow 
cytometer laser and a window emission range of 600 
to 630 nm for the CTC. This information allows the 
analysis of the bacterial metabolism because cells in 
the log phase emit red fluorescence and those in the 
stationary phase emit green fluorescence.
Data analysis
Descriptive analysis of the data, a multi-level 
analysis, ANOVA and post-hoc test (HSD Tukey) were 
performed to compare the groups with a 95% level 
of confidence. Data were analyzed using R software 
version 3.2.2.
RESULTS
Metabolism of ∂-ALA to PpIX into bacteria
The spectrofluorometer test (excitation of 375 nm) 
confirms the presence of PpIX with a wavelength of 
480 nm and an intensity of 1.30X105, demonstrating 
that PpIX was produced by E. faecalis after exogenous 
administration of δ-ALA (Figure 1, red line).
FIGURE 1 - Spectrofluorometry analysis of PpIX. The red 
line represents bacteria + ∂-ALA incubated for 13 min. The 
presence of PpIX after the exogenous administration of 
∂-ALA was demonstrated. The pink line represents bacteria 
+ ∂-ALA + laser irradiation (200 J/cm2). A decreased of the 
signal of PpXI after laser activation was shown. The results 
are the mean of the experiments.
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Photosensibilitation of PpIX
Bacterial samples were incubated with ∂-ALA, the 
precursor of PpIX. After the PpIX was identified by 
spectrofluorometry, the samples were irradiated with 
an argon laser at 510 nm (Leica Microsystems GmbH, 
Mannheim, Germany) for 8 min, 33 sec to reach a 
200 J/cm2 dose. Then, the samples were evaluated by 
spectrofluorometry to assess the signal of PpIX after 
irradiation. A decrease in the signal was found, (pink 
line), which could be interpreted as less availability of 
PpIX due to its photoactivation (Figure 1). 
Determination of the antibacterial effect 
of PpIX over planktonic E. faecalis
The multilevel model included the follow terms: 
groups (G1, G2, G3 and G4), time and the interaction 
term for both. According to the data, G4 show a lower 
number of CFUs compared with G2 (P<0.001) and G3 
(P=0.0167) at 0, 24 and 72 h. For G4 and G1 at 0, 24 
and 72 hours, there is no significant difference between 
groups (P=0.9685), indicating that the δ-ALA (40 µg/
mL) activated with the argon lase has an antibacterial 
effect similar to 5.25%NaOCl. For G2 and G3 at 0, 24 
and 72 h, there is no significant difference between 
groups (P<0.001), indicating that the application of 
either δ-ALA or laser alone has no antibacterial effect 
(Figures 2, 3). 
FIGURE 2 - Box-Plot: UFC vs Time for Group. Group 1 (G1), A positive control group treated with 800 µL of thioglycolate + 
200 µL of NaOCl 5.25%; group 2 (G2), 1 mL of thioglycolate + laser irradiation (8 min, 33 sec); group 3 (G3), 1 mL δ-ALA 
(40 µg/mL)-thioglycolate solution; and Group 4 (G4), 1 mL of δ-ALA (80 µg/mL)-thioglycolate solution + laser irradiation (8 
min, 33 sec). There was no significant difference between G4 and G1 at 0, 24 and 72 h. There is a statically significant for G4 
vs G2 and G3, at 0, 24 and 72 h. There was no significant difference between G2 and G3.
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FIGURE 3 - The image shows the bacterial cell culture at 
72 hrs. observed in a photodocument system (Bio-Rad of 
Quantity One). Group 1 (G1), a positive control group treated 
with 800 µL of thioglycolate + 200 µL of NaOCl 5.25%; 
group 2 (G2), 1 mL of thioglycolate + laser irradiation (8 min, 
33 sec); group 3 (G3), 1 mL δ-ALA (40 µg/mL)-thioglycolate 
solution; and group 4 (G4), 1 mL of δ-ALA (80 µg/mL)-
thioglycolate solution + laser irradiation (8 min, 33 sec). 
Yellow shows the UFCs of each of the groups, and there is a 
lower CFU amount in G4 compared to G2 and G3.
Determination of the antibacterial effect 
of PpIX over E. faecalis biofilm
The cell viability test evaluated by CTC of the 
biofilms treated with δ-ALA (80 µg/mL) and irradiated 
with an argon laser, 510 nm, 200 J/cm2 (group D), show 
a small number of bacteria compared with the groups 
not treated (group “b” and group “c”), demonstrating 
that the activation of PpIX by a laser has an antibacterial 
effect, even without biofilm disruption (Figure 4).
FIGURE 4 - LIVE/DEAD Test. Group “a” (GA), a positive 
control group treated with 800 µL of thioglycolate + 200 
µL of NaOCl 5.25%; group “b” (GB), 1 mL of thioglycolate 
+ laser irradiation (8 min, 33 sec), group “c” (GC), 1 mL 
δ-ALA (80 µg/mL)-thioglycolate solution; group “d” 
(GD), 1 mL of δ-ALA (80 µg/mL)-thioglycolate solution 
(5X107cells/mL) + laser irradiation (8 min, 33 sec). Group 
“a” show decomposition and an antibacterial effect on the 
biofilm treated with NaOCl 5.25%. Group “b” and group 
“c” do not show antibacterial effects or decomposition of 
the biofilm. Group “d” shows an antibacterial effect without 
decomposition of biofilm when exogenously administered 
δ-ALA and irradiated with an argon laser at 510 nm and 
200 J/cm2. 
DISCUSSION
PDT is a clinical procedure that has emerged as 
a non-invasive therapy for the treatment of infections 
(Dai et al., 2012; Rajesh et al., 2011) and represents an 
alternative to conventional pharmacological therapies. 
This therapy is a promising strategy to eliminate 
pathogenic microorganisms, including Gram-positive 
and Gram-negative bacteria, viruses, yeasts and fungi 
(Rajesh et al., 2011; Sperandio, Huang, Hamblin, 
2013), and its application could be particularly 
useful against resistant microorganisms or when 
traditional treatment does not completely eliminate 
microorganisms (Soukos et al., 2006). Additionally, it 
was shown that PDT not only kills the microorganism, 
but may also lead to the detoxification of endotoxins, 
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such as lipopolysaccharides (Rajesh et al., 2011). 
Another advantage of PDT over traditional antibiotic 
treatments is that with PDT, is possible avoid the 
appearance of undesired drug-resistant bacteria strains 
(Sperandio, Huang, Hamblin, 2013).
In the present study, the antibacterial effect of 
PDT on E. faecalis in planktonic and biofilm forms 
was evaluated using δ-ALA as a pre-photosensitizer 
in combination with an argon laser. The results 
obtained by spectrofluorometry verified that the δ-ALA 
administered to the microorganism is metabolically 
transformed in PpIX. When the PpIX was irradiated 
by an argon laser, the amount of PpIX was reduced, 
thereby decreasing the intensity of PpIX, indicating 
that the PpIX was activated by laser irradiation. This 
outcome also corroborated the antibacterial effect on 
microorganisms in planktonic and biofilm forms, even 
without biofilm disruption, comparable with the effect 
of sodium hypochlorite (NaOCl).
Biofilms on a variety of medical devices have been 
studied extensively over the past 25 years, and research 
on some of devices has demonstrated the susceptibility 
of most materials to microbial adherence and biofilm 
formation (Talsma, 2007). The use of δ-ALA may 
become an alternative or complement to solve this 
clinical issue of medical devices, even without biofilm 
mechanical disruption.
The results obtained in this study are consistent 
with data reported previously about the use of PDT to 
treat bacterial infections (Kharkwal et al., 2011), which 
concluded that although PDT has some limitations that 
need to be overcome, it has the potential to be used to 
treat a number of infectious diseases. 
The present results are similar to data obtained by 
López-Jiménez et al. (2015), who evaluated the effect 
of toluidine blue and methylene blue as PS agents in 
combination with a light-emitting diode, at 628 nm, 30 
J, on a biofilm of an ATCC 29212 of E. faecalis. They 
reported that this protocol has effective antibacterial 
activity, and they also evaluated the surface of the biofilm 
treated with PDT by atomic force microscopy, reporting 
that the topography of the biofilm was modified after 
PDT treatment with an increase in the roughness of the 
surface of the biofilm. This effect could be beneficial 
because this could expose the bacteria of biofilms to 
the PS agent and light, producing a better antibacterial 
effect. It is important to highlight that toluidine blue and 
methylene do not a have wide range of activation such as 
PpIX, limiting its application to certain tissues.
In this study, a dose of 200 J/cm2 was used based on 
the results reported by Li et al. (2013) who evaluated the 
use of δ-ALA on biofilm of methicillin-resistant strains 
(S. aureus and S. epidermidis), and reported that δ-ALA 
was absorbed and converted to PpIX by both types of 
bacteria strains. After the samples were irradiated with 
a semiconductor laser at different potencies (0, 100, 
200, and 300 J/cm2), an antibacterial effect was shown 
directly proportional to the dose of J/cm2 administered 
with a max response at 200-300 J/cm2. The present results 
are consistent with these data, showing the presence of 
PpIX after the exogenous administration of δ-ALA and 
a reduction in the amount of PpIX after laser irradiation. 
The results also showed an antibacterial effect at a laser 
dose of 200 J/cm2.
Fotinos et al. (2008) demonstrated the ability 
to inactivate Gram-positive (methicillin-resistant S. 
aureus) and Gram-negative (two E. coli strains and a 
P. aeruginosa strain) bacteria by photodynamic therapy 
after incubation with δ-ALA. An inactivation rate 
of 99.9% was reported for both E. coli strains and P. 
aeruginosa. S. aureus was significantly more sensitive 
to δ-ALA porphyrins, with a survival rate even lower 
than the Gram-negative strains, demonstrating the 
antibacterial effect of porphyrins metabolized from 
δ-ALA on Gram-positive and Gram-negative bacteria. 
Similar results were obtained in this study, in which 
Gram-positive bacteria (E. faecalis) in planktonic and 
biofilm forms were used, demonstrating that activation 
of PpIX by an argon laser has an antibacterial effect 
even in the presence of a biofilm.
As previously discussed, the microorganisms in a 
biofilm are more resistant to antimicrobials (Balcázar, 
Subirats, Borrego, 2015; Donelli, 2014; Donlan, 2011; 
Li et al., 2013; López-Jiménez et al., 2015), and the 
most common methods to treat and eliminate biofilms 
are mechanical disruption and antimicrobial therapy; 
however, the efficacy of these strategies is limited 
(López-Jiménez et al., 2015; Rajesh et al., 2011). In this 
study, it was shown that the disruption of the biofilm 
is not necessary to inactivate the bacteria with the 
use of exogenously administered δ-ALA to produce 
intracellular PpIX. Barra et al. (2015) evaluated the 
application of δ-ALA and light-emitting diode irradiation 
on bacteria biofilms (S. aureus, S. epidermidis, and S. 
haemolyticus) using a viability cell test. It was shown 
that the viability of the three bacteria in the biofilm 
was reduced to 20% of the original values, but it was 
necessary to increase the light dose administered to 
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reach adequate bacterial inactivation, indicating that 
the light dose is a critical factor to achieve the desire 
effect. In the present study, it was necessary to increase 
the concentration of ∂-ALA to achieve an antibacterial 
effect on the biofilm. This may be because the biofilm 
acts a semi-barrier that limits the penetration of ∂-ALA 
to the bacteria cells.
One of the main disadvantages related to the 
clinical application of PDT is that the PS agents have 
specific absorption peaks, limiting the use of certain 
types of light sources, and in some cases the wavelength 
used cannot penetrate deep tissues. With δ-ALA as a 
pre-photosensitizer, it is possible to overcome this 
clinical situation because PpIX has different absorption 
peaks (410 nm, 510 nm, 545 nm, 580 nm, and 635 nm) 
(Hino et al., 2013), offering the ability to be activated by 
different sources of light at different wavelengths, thus 
making it useful to treat bacterial infections on dermis 
and epidermis tissues (Sperandio, Huang, Hamblin, 
2013; Wachowska et al., 2011). Furthermore, δ-ALA has 
several advantages over other photosensitizers. It has 
a rapid metabolism and high selectivity for malignant 
lesions (Wachowska et al., 2011) and bacteria (Barra 
et al., 2015). In this study, all treatment groups incubated 
with δ-ALA show an antibacterial effect, including 
the G3 (δ-ALA, without laser irradiation). Finally, the 
rapid systemic clearance of ALA-induced PpIX within 
24 h eliminates prolonged photosensitivity and allows 
treatment to be repeated at regular intervals without 
cumulative effects and the risk of damage to tissues 
(Wachowska et al., 2011).
The production and accumulation of PpIX induced 
by an exogenously administered δ-ALA on E. faecalis 
biofilms was shown. The photoactivation of PpIX with 
an argon laser produced an antibacterial effect even 
without disruption of the biofilm. From our results, this 
therapy could become an alternative to conventional 
mechanical disruption or pharmacological therapies 
for the treatment of bacterial infections related to the 
presence of biofilm on biomedical devices that cannot 
be used treated with sodium hypochlorite. Exhaustive 
in vitro and in vivo studies are required to fully support 
the use of this methodology as an alternative or 
complementary method to treat bacterial infections.
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